Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

Broadly targeted human cytomegalovirus-specific CD4 <b>+</b> and CD8 <b>+</b> T cells dominate the memory compartments of exposed subjects

Andrew Sylwester, Bridget L. Mitchell, John B. Edgar et al. · The Journal of Experimental Medicine · 2005 · 1.3K citations · Full text

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

Paola Panina‐Bordignon, Agnes L. Tan, A. Termijtelen et al. · European Journal of Immunology · 1989 · 707 citations

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL

Mark R. Wills, A.J. Carmichael, Kim Mynard et al. · Journal of Virology · 1996 · 686 citations · Full text

Histocompatibility, Normal Virus Carrier, Multiple Pp65 Peptides +15

Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

Gunther Hartmann, Arthur Μ. Krieg · The Journal of Immunology · 2000 · 599 citations

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides

Jeff Alexander, John Sidney, Scott Southwood et al. · Immunity · 1994 · 525 citations

Peptide Library, Peptide Engineering, Immunology +7